Literature DB >> 21327156

Transcriptional regulation of the human telomerase reverse transcriptase: new insights.

Amel Chebel1, Martine Ffrench.   

Abstract

hTERT and NFAT were thought until recently to belong to separate metabolic compartments. The involvement of NFAT in the induction of hTERT transcription suggested by hTERT expression variations during lymphocyte stimulation and immunosuppressive treatments explains the link between hTERT expression and cell stimulation and offers new insights for therapeutic developments.

Entities:  

Keywords:  NFAT; cell stimulation; hTERT; immunosuppression; tumorigenesis

Mesh:

Substances:

Year:  2010        PMID: 21327156      PMCID: PMC3035187          DOI: 10.4161/trns.1.1.12062

Source DB:  PubMed          Journal:  Transcription        ISSN: 2154-1272


  34 in total

1.  Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes.

Authors:  K Liu; M M Schoonmaker; B L Levine; C H June; R J Hodes; N P Weng
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  The age-related decline in the induction of IL-2 transcription is correlated to changes in the transcription factor NFAT.

Authors:  M A Pahlavani; M D Harris; A Richardson
Journal:  Cell Immunol       Date:  1995-10-01       Impact factor: 4.868

3.  Extension of life-span by introduction of telomerase into normal human cells.

Authors:  A G Bodnar; M Ouellette; M Frolkis; S E Holt; C P Chiu; G B Morin; C B Harley; J W Shay; S Lichtsteiner; W E Wright
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

4.  Telomerase regulation during entry into the cell cycle in normal human T cells.

Authors:  K J Buchkovich; C W Greider
Journal:  Mol Biol Cell       Date:  1996-09       Impact factor: 4.138

5.  The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats.

Authors:  G B Morin
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

6.  The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity.

Authors:  C W Greider; E H Blackburn
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

7.  Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene.

Authors:  I Horikawa; P L Cable; C Afshari; J C Barrett
Journal:  Cancer Res       Date:  1999-02-15       Impact factor: 12.701

8.  Expression of TERT in early premalignant lesions and a subset of cells in normal tissues.

Authors:  K A Kolquist; L W Ellisen; C M Counter; M Meyerson; L K Tan; R A Weinberg; D A Haber; W L Gerald
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

9.  The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate.

Authors:  E Smeland; T Godal; E Ruud; K Beiske; S Funderud; E A Clark; S Pfeifer-Ohlsson; R Ohlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

10.  Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts.

Authors:  G A Ulaner; J F Hu; T H Vu; L C Giudice; A R Hoffman
Journal:  Cancer Res       Date:  1998-09-15       Impact factor: 12.701

View more
  3 in total

Review 1.  Expression and regulation of telomerase in human T cell differentiation, activation, aging and diseases.

Authors:  Michael Patrick; Nan-Ping Weng
Journal:  Cell Immunol       Date:  2019-09-19       Impact factor: 4.868

Review 2.  Regulation of the human catalytic subunit of telomerase (hTERT).

Authors:  Michael Daniel; Gregory W Peek; Trygve O Tollefsbol
Journal:  Gene       Date:  2012-02-13       Impact factor: 3.688

3.  Modelling TERT regulation across 19 different cancer types based on the MIPRIP 2.0 gene regulatory network approach.

Authors:  Alexandra M Poos; Theresa Kordaß; Amol Kolte; Volker Ast; Marcus Oswald; Karsten Rippe; Rainer König
Journal:  BMC Bioinformatics       Date:  2019-12-30       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.